Transfection Reagent and Equipment Market Report: Trends, Forecast and Competitive Analysis to 2030

Transfection Reagent and Equipment Trends and Forecast

The future of the global transfection reagent and equipment market looks promising with opportunities in the academic & research institute and parmaceutical & biotechnology company markets. The global transfection reagent and equipment market is expected to reach an estimated $1.9 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing burden of chronic diseases across the globe, high demand for synthetic genes, and technological advancements in transfection.

A more than 150-page report is developed to help in your business decisions.

Transfection Reagent and Equipment by Segment

The study includes a forecast for the global transfection reagent and equipment by product, method, application, end use, and region.

Transfection Reagent and Equipment Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Reagents
• Equipment

Transfection Reagent and Equipment Market by Method [Shipment Analysis by Value from 2018 to 2030]:

• Physical Methods
• Biochemical Methods
• Viral Methods

Transfection Reagent and Equipment Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Protein Production
• Biomedical Research
• Therapeutic Delivery

Transfection Reagent and Equipment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Academics & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

Transfection Reagent and Equipment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Transfection Reagent and Equipment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transfection reagent and equipment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transfection reagent and equipment companies profiled in this report include-

• PromoCell
• OriGene Technologies
• Thermo Fisher Scientific
• Merck
• Bio-Rad Laboratories
• Lonza
• Qiagen N.V.
• Mirus Bio
• Promega Corporation
• F. Hoffmann-La Roche

Transfection Reagent and Equipment Market Insights

Lucintel forecasts that reagents is expected to witness the higher growth over the forecast period due to huge number of launches by key players so as to broaden their reagents portfolio.

Within this market, pharmaceutical & biotechnology companies will remain the largest segment due to increasing burden of diseases and rising adoption of reagent and equipment worldwide.

North America will remain the largest segment over the forecast period due to rising investments in research and development in genomics, growing demand for protein therapeutics, and the existence of major players in the region.

Features of the Global Transfection Reagent and Equipment Market

Market Size Estimates: Transfection reagent and equipment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Transfection reagent and equipment market size by various segments, such as by product, method, application, end use, and region in terms of value ($B).

Regional Analysis: Transfection reagent and equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, methods, applications, end uses, and regions for the transfection reagent and equipment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transfection reagent and equipment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the transfection reagent and equipment market size?

Answer: The global transfection reagent and equipment market is expected to reach an estimated $1.9 billion by 2030.

Q2. What is the growth forecast for transfection reagent and equipment market?

Answer: The global transfection reagent and equipment market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the transfection reagent and equipment market?

Answer: The major drivers for this market are increasing burden of chronic diseases across the globe, high demand for synthetic genes, and technological advancements in transfection.

Q4. What are the major segments for transfection reagent and equipment market?

Answer: The future of the transfection reagent and equipment market looks promising with opportunities in the academic & research institute and parmaceutical & biotechnology company markets.

Q5. Who are the key transfection reagent and equipment market companies?

Answer: Some of the key transfection reagent and equipment companies are as follows:

• PromoCell
• OriGene Technologies
• Thermo Fisher Scientific
• Merck
• Bio-Rad Laboratories
• Lonza
• Qiagen N.V.
• Mirus Bio
• Promega Corporation
• F. Hoffmann-La Roche

Q6. Which transfection reagent and equipment market segment will be the largest in future?

Answer: Lucintel forecasts that reagents is expected to witness the higher growth over the forecast period due to huge number of launches by key players so as to broaden their reagents portfolio.

Q7. In transfection reagent and equipment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to rising investments in research and development in genomics, growing demand for protein therapeutics, and the existence of major players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the transfection reagent and equipment market by product (reagents and equipment), method (physical methods, biochemical methods, and viral methods), application (protein production, biomedical research, and therapeutic delivery), end use (academics & research institutes, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?